Related Experiment Videos
Magnetization transfer contrast imaging in Niemann pick type C mouse liver
Jingyu Guo1, Robert Erickson, Theodore Trouard
1Physiological Sciences Program, University of Arizona College of Medicine, Tucson, Arizona 85724, USA. gillies@u.arizona.edu
Journal of Magnetic Resonance Imaging : JMRI
|August 26, 2003
Summary
Magnetization transfer contrast (MTC) imaging revealed significant changes in the livers of mice with Niemann-Pick type C (NP-C) disease. This technique shows potential for monitoring NP-C progression and therapy.
Area of Science:
- Biomedical imaging
- Metabolic disorders
- Hepatology
Background:
- Niemann-Pick type C (NP-C) disease is a fatal genetic lipid metabolism disorder.
- Characterized by cholesterol and ganglioside accumulation, primarily affecting the brain and liver.
- Previous research suggests magnetization transfer (MT) is sensitive to tissue composition, including cholesterol and collagen.
Purpose of the Study:
- To evaluate the utility of magnetization transfer contrast (MTC) imaging in assessing NP-C disease in mouse livers.
- To determine if the MT ratio (MTR) changes predictably with disease progression in NP-C mice.
Main Methods:
- Mice with NP-C disease and control mice were studied.
- Magnetization transfer contrast (MTC) imaging was performed on liver tissues.
- The MT ratio (MTR) was calculated and compared between groups during disease progression and therapy.
Main Results:
- Significant differences in MTR were detected between NP-C and control mouse livers.
- Observed MTR changes correlated with collagen deposition and fibrosis, not unesterified cholesterol accumulation.
- MTR demonstrated reproducibility during disease progression in the studied mice.
Conclusions:
- MTC imaging shows promise as a non-invasive tool for monitoring NP-C disease progression.
- This imaging technique may aid in evaluating therapeutic interventions for NP-C disease.
- MTR changes reflect fibrotic alterations in the liver during NP-C.